Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience

A Vianello; M Caminati; M Andretta; A M Menti; S Tognella; G Senna; L Degli Esposti

doi:10.1016/j.waojou.2019.100032

Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience

World Allergy Organ J. 2019 May 10;12(4):100032. doi: 10.1016/j.waojou.2019.100032. eCollection 2019.

Authors

A Vianello^{1

2

3

4

5

2

6}, M Caminati^{2

3

4

5

2

6}, M Andretta^{4

5

2

6}, A M Menti^{4

5

2

6}, S Tognella^{5

2

6}, G Senna^{2

6}, L Degli Esposti⁶

Affiliations

¹ Respiratory Pathophysiology Division, University-City Hospital of Padua, Padua, Italy.
² Asthma Center and Allergy Unit, Verona University and General Hospital, Verona, Italy.
³ Department of Medicine, University of Verona, Verona, Italy.
⁴ Health Technology Assessment Unit, Azienda Zero, Padova, Italy.
⁵ Respiratory Unit, Orlandi General Hospital, Bussolengo, Verona, Italy.
⁶ CliCon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy.

No abstract available

Keywords: Asthma; Asthma prevalence; Severe asthma; Treatment adherence.